AI
How AI helps scientists design the next generation of medicines
MIT Technology Review AIThursday, July 23, 2026 at 12:00 PM
RedScroll Brief
Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment.
Desk copy
RedScroll Briefing
Extractive editorial brief — not a reprint of the original
What happened
Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment.
Why it matters
AI developments move capital, regulation, and competitive advantage across the tech stack.
Background
MIT Technology Review AI reported on this under ai. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.
Timeline
MIT Technology Review AI published: How AI helps scientists design the next generation of medicines
Story is in today’s RedScroll edition. Follow the original source for updates.
Economic impact
Secondary effects may show up in markets and supply chains linked to AI and Helps.
More on
AI
Related stories
- 5 ways AI Mode in Search helps you enjoy the real world
Google AI BlogAI
- Advancing next-gen AI with materials science innovation
MIT Technology Review AIAI
- Are brain waves the next unlock for physical AI?
TechCrunchTECHNOLOGY
- Scientific computing in the age of agentic AI
OpenAI NewsAI
- Launching Health in ChatGPT
OpenAI NewsAI
- Building AI infrastructure with the Effingham County community
OpenAI NewsAI
Sources
MIT Technology Review AI — original reporting. RedScroll provides an extractive briefing only.